The Neurology Academy hosted a debate at the ABN conference this year to discuss the newly proposed NHS England algorithm for using disease-modifying treatments (DMTs) to manage multiple sclerosis (MS).
We interviewed a number of key people at the debate on 9th May to help get a clearer and fuller picture of what this algorithm will mean for both clinical practice and patient experience.
Prof Gavin Giovannoni and Dr David Paling, both eminent neurologists specialising in MS, were the main voices of the debate. Listen to this short video clip to understand their core arguments around:
- Why the algorithm has been made
- What the potential benefits and challenges will be nationally
- Why patients may welcome the algorithm
Interested in what they’re saying? Come and listen to the full debate and our other soundbites, presenting everything from the patient view to an Industry perspective.
Posted in: Multiple Sclerosis